Nebula Research & Development »

Kiniksa Pharmaceuticals shares owned by Nebula Research & Development

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Nebula Research & Development from 13F filings

Historical chart of Nebula Research & Development investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Nebula Research & Development consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Nebula Research & Development

Quarter filed Position value Share count Share price at filing
2023-09-30 $238k 14k 17.37

More positions owned by Nebula Research & Development

Intuit (INTU)
Power Integrations (POWI)
Archer Daniels Midland Company (ADM)
Federated Hermes CL B (FHI)
Loews Corporation (L)
Hca Holdings (HCA)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)
Abbott Laboratories (ABT)
Insight Enterprises (NSIT)
S&p Global (SPGI)
Peak (DOC)
Nomad Foods Usd Ord Shs (NOMD)
Union Pacific Corporation (UNP)
Cigna Corp (CI)

View all positions for Nebula Research & Development

Top funds holding Kiniksa Pharmaceuticals

Vanguard Group
Fairmount Funds Management
Baker Bros. Advisors
Goldman Sachs Group
Arrowpoint Asset Management
Rice Hall James & Associates
Tang Capital Management
Caption Management
Altitude Crest Partners
Millennium Management
Dimensional Fund Advisors
GMT Capital Corp
Walleye Trading Advisors
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Kiniksa Pharmaceuticals